FIT Biotech

Our vision

Our mission is to be a globally recognized DNA-vaccine and gene therapy company, through our own research.

Read more

  • Our success

    We measure our success in the value of human life

FIT Biotech aims to make a difference.

R&D Publications

Company release June 26th, 2015

Company release June 26th, 2015

FIT Biotech’s Initial Public Offering Completed Successfully

Read more

Yhtiötiedote 26.6.2015

Yhtiötiedote 26.6.2015

FIT Biotechin listautumisanti toteutunut onnistuneesti

Lue lisää

Company release June 16th, 2015

Company release June 16th, 2015

FIT Biotech Company release extension of subscription period has been published

Read more

Yhtiötiedote 16.6.2015

Yhtiötiedote 16.6.2015

FIT Biotech Yhtiötiedote merkintäajan pidentämisestä julkaistu

Lue lisää

Company release June 1st, 2015

Company release June 1st, 2015

FIT Biotech Ltd’s listing prospectus has been published

Read more

RESEARCH & DEVELOPMENT

FIT Biotech’s most important R&D activity since the start of its operations has been the development of an HIV vaccine.

R&D Publications